Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

20. August 2021 - 0:00 (CEST)

Epigenomics AG: Reduction of principal amount of planned mandatory convertible bond to up to EUR 16.5 million and of conversion price to EUR 1.10 per share

Read more

17. August 2021 - 0:00 (CEST)

Epigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance

Read more

11. June 2021 - 0:00 (CEST)

Epigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18.15 million

Read more

Press releases

18. November 2021

Supervisory Board of Epigenomics AG Appoints Dr. Andrew Lukowiak as President and Chief Scientific Officer

Read more

10. November 2021

Epigenomics AG publishes financial results for the first nine months 2021

Read more

07. October 2021

Epigenomics AG: EVP of Finance Albert Weber leaves the Company

Read more